SAN DIEGO, Feb. 24, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the ...
On Dec. 9-10, skywatchers across parts of Canada, the U.S. and Europe will witness a very rare occultation of the bright star ...
Tonight, look up in the sky. Look east and you will see the moon and Regulus unite, giving all of the residents of Earth (who are keen on stargazing) a unique concert. This concert begins in the ...
The article details the celestial configuration of the waning Moon and Regulus in the constellation Leo for observation on October 15. Regulus is identified as a magnitude 1.4, quadruple-star system, ...
Maybe the third time's the charm? Regulus Therapeutics is once again shuffling its pipeline and sliding a new kidney disease candidate into the high-priority queue, hoping for better fortunes after a ...
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a rare ...
TOLEDO, Ohio — If you’re an early riser (or willing to become one), the morning of Saturday, Sept. 20, promises one of the best naked-eye sky events of the year: a slim crescent moon, the brilliant ...
Embattled biotech Regulus Therapeutics suffered another blow today after revealing AstraZeneca handed back rights to a clinical-stage drug for nonalcoholic steatohepatitis (NASH). AstraZeneca has said ...
Looking for a sky event this week? Check out our full Sky This Week column. October 15: Check out Comet Lemmon The waning Moon has moved into Leo and stands close to Regulus, the Lion's bright heart, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback